#JPM21: Reshma Kewalramani is on the hunt for 'mid-to late-stage assets,' new tools to replenish Vertex pipeline
It’s her first JP Morgan as CEO of Vertex, and Reshma Kewalramani is hitting the ground running.
The partnerships she inherited from predecessor Jeff Leiden have produced a slate of programs that, while promising, are either preclinical or just wrapping up human proof-of-concept. But for 2021, Kewalramani has outlined a plan to bring in more mid-to late-stage assets — alongside and tools to expand our toolkit.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.